Navigation Links
96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
Date:9/1/2008

PALO ALTO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new filtration plate for sample preparation. Captiva(TM) NDLipids is a simple to use, non-drip 96-well plate specially designed to remove phospholipids including lysophosphatidylcholines, from biofluids.

It is intended for use by analytical chemists in the pharmaceutical and life science industries performing quantitative and qualitative analyses of drugs in biofluids. In applications such as drug screening and monitoring in early discovery, pre-clinical and clinical trials, the lipids, proteins and surfactants in a biofluid sample must be removed before analysis by liquid chromatography/mass spectroscopy (LC/MS). Incomplete removal leads to ion suppression (reduced sensitivity) and, over time, degrades the performance of both the LC column, reducing column life, and the MS ion source, increasing maintenance.

Using Captiva NDLipids, plasma extracts are virtually free from endogenous matrix interferences (over 97% of the phosphatidylcholines are removed). Ion suppression is significantly reduced resulting in enhanced sensitivity and precision during trace analysis. The removal of lipid compounds results in better peak shapes and more reproducible retention times so that Standard Operating Procedure (SOP) parameters are easily validated. A fast, 3-step, in-well precipitation protocol is applicable to a wide variety of analytes. This ensures high sample throughputs and avoids the need for extensive methods development.

"Captiva NDLipids is a double win for our customers," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "The efficient removal of matrix interferences offers improved analytical sensitivity, and the simple clean up method leads to productivity enhancements."

For more technical information about Varian products, please visit htt
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
2. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
3. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
4. New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy
7. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
8. Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
9. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
10. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
11. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., N.Y., Nov. 9 /PRNewswire/ -- On Sept. 11, 2001...ther rescue workers came together to save as many ...ghter Brian McCauley was one of those 9/11 first r.... ,, Only in his late 30s, McCauley was diagnos...nd extensive chemotherapy treatments, leaving him ...
(Date:11/9/2009)..., Nov. 9 Women,s sexual health com...name to Viveve as it prepares for a 2010 launch of...ts. ,, "Viveve is a name that we believe captur...ual health," said Kerry Pope, Viveve,s president a...rpose of helping women restore their sense of fulf...
(Date:11/9/2009)...v. 9 Boston Scientific C...h of its COGNIS® cardiac resynchronization th...antable cardioverter defibrillator (ICD) in Japan....stry of Health, Labor and Welfare (MHLW) in August... COGNIS and TELIGEN are the result of a multi-yea...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4NeurogesX Appoints New Board Director and Audit Committee Chairman 13680 1NeurogesX Appoints New Board Director and Audit Committee Chairman 13680 2NeurogesX Appoints New Board Director and Audit Committee Chairman 13680 3NeurogesX Appoints New Board Director and Audit Committee Chairman 13680 4NeurogesX Appoints New Board Director and Audit Committee Chairman 13680 5Grubb 26 Ellis Healthcare REIT II Declared Effective by the U S Securities and Exchange Commission 55245 1Consolidation Among Chicago Physicians Likely to Increase 55243 1Consolidation Among Chicago Physicians Likely to Increase 55243 2Consolidation Among Chicago Physicians Likely to Increase 55243 3
...WN, W.Va., Sept. 5 A team of,researchers at West ... from,India and Pakistan take on the habits of the...tate cancer among male immigrants and breast cance...cer develop due to many reasons, but,environmental...cancers,",said Jame Abraham, M.D., medical directo...
...Roche first in TaqMan(R) real-time PCR testing for...ab, PLEASANTON, Calif., Sept. 4 The U.S. Food & ...OBAS(R) TaqMan(R) HBV Test,the first assay for qua...S.,The test uses Roche,s real-time PCR technology ... a patient,s blood. Doctors may use viral load,tes...
Other Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3
(Date:11/9/2009)...tary Vilsack, Governor Patrick, and Lieutenant Gov...ewswire/ -- In a groundbreaking move for antihunge...) called for all of the state,s hospitals to take ... care. ,, "With 554,000 people in Massachusett...ss conference at UMass Memorial Health Care in Wor...
(Date:11/9/2009)...wswire/ -- The House version of health care reform...hich passed by a vote of 220-215 on Saturday, Nove...s to the tax code and differs in many ways from th...rsion, requiring extensive reconciliation to reach...riefing on the tax provisions of the legislation...
(Date:11/9/2009)...Obama,s promise to not expand abortion ,, Sen...l concerned for poor, elderly ,, WASHINGTON, N...George of Chicago, president of the United States ...r 7 decision of the U.S. House of Representatives ...ing for elective abortions. ,, In a statement ...
(Date:11/9/2009)...qually, study finds, , , MONDAY, Nov. 9...ng drug Plavix (clopidogrel) works about the same ...trials has found. , "After this study, I can sa...en with this very important drug," said Dr. Jeffre... at New York University Langone Medical Center in ...
(Date:11/9/2009)...could boost self-esteem, researchers say , ...hildren are more likely to have handwriting proble...without autism, researchers say. , The new stud...study participants had autism spectrum disorder, b...nge for perceptual reasoning on an IQ test. , T...
Breaking Medicine News(10 mins):Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 2Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 3Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Handwriting Skills May Lag in Kids With Autism 2
... The U.S. Food and Drug Ad...tment for vertigo and dizziness which helps guide ...he U.S. , Calgary, Canada...atment for vertigo] and dizziness which helps guid...
... The latest edition of the...magazine Inc. has made it official -Brightway Insu... property and casualty insurance agency in the cou...ness magazine Inc. has made it official -Brightway...
...ndomized, double-blind, placebo-controlled study c...acy and safety of Nasacort AQ(R) in children wi...ic rhinitis, BRIDGEWATER, N.J., Sept. 23 Sanofi-...-5,years old for the treatment of nasal symptoms a...
...irteenth Trial Conviction for Medicare Fraud Strik...federal jury in Los,Angeles today convicted the ow...Angeles based durable medical equipment (DME) comp...l District of,California Thomas P. O,Brien announc...
...NTA ANA, Calif., Sept. 22 Grubb & Ellis,Healthcar...lahoma City,Medical Portfolio, comprising two medi...5401 and 5701 N. Portland, the buildings are situa...ttractive additions to the Grubb,& Ellis Healthcar...
...mantic search leader hakia will expand its credibi...tent, WASHINGTON, Sept. 22 Semantic search engin... and information professionals to,participate in a...ical searches to guide users towards credible Web,...
Other Medicine News:Health News:Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA 2Health News:Brightway Insurance Earns a Spot on the INC 5000 2Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 2Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 3Health News:FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old 4Health News:Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to Medicare 2Health News:Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to Medicare 3Health News:Grubb & Ellis Healthcare REIT Acquires Oklahoma City Medical Portfolio 2Health News:Grubb & Ellis Healthcare REIT Acquires Oklahoma City Medical Portfolio 3Health News:hakia Issues Open Call to Librarians and Information Professionals: Help Us Guide Web Searchers to Credible Web Sites 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: